Literature DB >> 26402655

Liver transplantation for nonalcoholic steatohepatitis in young patients.

Naim Alkhouri1, Ibrahim A Hanouneh1, Nizar N Zein1, Rocio Lopez2, Dympna Kelly1, Bijan Eghtesad1, John J Fung1.   

Abstract

Nonalcoholic steatohepatitis (NASH) is the hepatic manifestation of obesity and insulin resistance. The aim of this study was to determine the frequency of NASH as an indication for liver transplantation (LT) in children and young adults and to characterize patient and graft survival. The study included all children and young adult patients (up to the age of 40 years) who underwent LT in the United States for NASH cirrhosis from the 1987 to 2012 United Network for Organ Sharing (UNOS) database. Kaplan-Meier analysis was used to assess patient and graft survival. A total of 330 patients were included, 68% were Caucasian, and the mean BMI was 33.6 ± 6.3. Age at time of LT ranged between 4 and 40 years (mean 33.9 ± 6.6 years). Fourteen subjects were <18 years of age at time of LT and 20 were between the ages of 18 and 25 years. Median follow-up after 1st LT was 45.8 months [10.7, 97.3]. During this time, 30% of subjects (n = 100) died and 11.5% (n = 38) were retransplanted including 13 for NASH recurrence. In conclusion, NASH can progress to end-stage liver disease requiring LT in childhood and early adulthood. A significant number of young patients transplanted for NASH cirrhosis required retransplantation.
© 2015 Steunstichting ESOT.

Entities:  

Keywords:  children; cryptogenic cirrhosis; liver transplantation; nonalcoholic steatohepatitis; young adults

Mesh:

Year:  2016        PMID: 26402655     DOI: 10.1111/tri.12694

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  20 in total

1.  Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.

Authors:  Iliana Doycheva; Kymberly D Watt; Ghassoub Rifai; Rachel Abou Mrad; Rocio Lopez; Nizar N Zein; William D Carey; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

Review 2.  Clinical advances in pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer
Journal:  Hepatology       Date:  2016-03-04       Impact factor: 17.425

Review 3.  Hepatic Steatosis in the Pediatric Population: An Overview of Pathophysiology, Genetics, and Diagnostic Workup.

Authors:  Claudia Phen; Charina M Ramirez
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

4.  Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease.

Authors:  Toshifumi Yodoshi; Sarah Orkin; Ana Catalina Arce-Clachar; Kristin Bramlage; Chunyan Liu; Lin Fei; Faris El-Khider; Srinivasan Dasarathy; Stavra A Xanthakos; Marialena Mouzaki
Journal:  Eur J Clin Nutr       Date:  2019-08-23       Impact factor: 4.016

Review 5.  NASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?

Authors:  Ali Canbay; Jan-Peter Sowa; Wing-Kin Syn; Jürgen Treckmann
Journal:  Visc Med       Date:  2016-07-29

Review 6.  Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Valerio Nobili; Anna Alisi; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  Gastroenterology       Date:  2016-03-19       Impact factor: 22.682

7.  Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Jay Shah; Toluwalase Okubote; Naim Alkhouri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-07

Review 8.  Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter.

Authors:  Praveen Kumar Conjeevaram Selvakumar; Mohammad Nasser Kabbany; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

9.  Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Miriam B Vos; Lara Dimick-Santos; Ruby Mehta; Stephanie O Omokaro; Johannes Taminiau; Elmer Schabel; David E Kleiner; Peter Szitanyi; Piotr Socha; Jeffrey B Schwimmer; Stephanie Noviello; Debra G Silberg; Richard Torstenson; Veronica Miller; Joel E Lavine
Journal:  Gastroenterology       Date:  2019-09-12       Impact factor: 22.682

10.  Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.

Authors:  Shima Dowla; Stella Aslibekyan; Amy Goss; Kevin Fontaine; Ambika P Ashraf
Journal:  J Clin Lipidol       Date:  2018-04-03       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.